The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coverage in the US: a map of the usual obstacles

This is a generated summary. It shows the 7 most-liked posts from a topic of 51, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
KH
ka.haddadTL224 Oct 2025#4

What would change my mind on coverage is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

28 likes 9mo
FK
f.kimaniTL26 Dec 2025#19
j.iyer, post #11: Adding the measurement that post #10 says would settle it. Nobody has said the unglamorous part of coverage yet, so: most of the variation is explained by things that are boring to write about and easy to check. Go to post

The confident answers on coverage and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

20 likes in reply to #11 8mo
TI
trough_indexTL3Regular16 Dec 2025#23

Second this, and I would have said it less carefully.

30 likes 7mo
L
LJankowiakTL3Regular25 Dec 2025#27

The honest answer on coverage is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.

Most people get the first two right and then argue about the fourth.

22 likes 7mo
N
NicolaidesTL3Regular12 Jan 2026#35

Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different.

If that reads as pedantic, it is, and it has saved me twice.

26 likes 6mo
CL
customs_ledgerTL3Regular25 Jan 2026#41

Right — I had this wrong and I am glad to have read it before it mattered.

27 likes 6mo
JF
j.falkTL212 Feb 2026#50

The documentation on coverage is better than this thread and I say that as someone who has posted in the thread.

26 likes 5mo

Read the full topic (51 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
POCLNNTPFV+74 80 7.7k 18mo
Revisiting: US compounding rules and how they changed
On the subject in the title: Revisiting: US compounding rules and how they changed Working notes rather than a conclusion. Regional question, dated February 2026, because everything in this category expires.…
LECKDHKI+5 9 26k 23mo
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…
SAEDERSGAK 4 62k 9mo
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Telehealth prescribing models — I have the observation and I do not trust my…
LCNBHFTIEM+26 30 17k 17h
Canadian access and provincial variation — one year on
Canadian access and provincial variation — one year on Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about Canadian access and provincial variation…
EOHFCRJSRM+43 47 964 12mo

Related topics — sharing the tags FDA, insurance, telehealth

TopicParticipantsRepliesViewsActivity
About the North America category
US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…
KTVEKCNB+3 7 43k 9mo
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
SCHBFPNVHS+20 25 50k 1d
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. Official shortage notices — I have the observation and I do not trust my…
SPVBAKTWFA+85 92 5.5k 11mo
Coverage for the indication versus for the drug — a second dataset
On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and…
TSEFKJHV+46 50 41k 16mo
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…
SAEDERSGAK 4 62k 9mo